Search Results for agency_names:"National Institutes of Health"

The National Cancer Institute announced several upcoming closed meetings to review grant applications and contract proposals. These meetings will not be open to the public to protect confidential information and personal privacy. Each meeting is led by a Scientific Review Officer, and the topics include reviews for SBIR contracts, clinical and translational research, and various other cancer research initiatives. The meetings will take place via telephone conference calls from late February through early April 2021.

The National Institute of Neurological Disorders and Stroke is changing the dates for their upcoming special meeting. Originally scheduled for February 25-26, 2021, the meeting will now take place on April 14-15, 2021. The meeting will still be held at the Neuroscience Center in Rockville, Maryland, and it remains closed to the public. The timing of the meeting will stay the same as initially planned.

The National Institutes of Health (NIH) has announced a closed meeting of the Center for Scientific Review Special Emphasis Panel focused on the Neurobiology of Pain and Itch. The meeting will take place virtually on January 6, 2025, from 11:00 a.m. to 2:00 p.m. During this meeting, grant applications will be reviewed and evaluated, and it will be closed to the public to protect confidential information and maintain privacy. The contact person for this meeting is Dr. Anne-Sophie Marie Lucie Wattiez, a Scientific Review Officer at the NIH.

The National Cancer Institute announced that it will hold two closed meetings in March 2025 to discuss and evaluate grant applications. The meetings will not be open to the public because they might involve discussing confidential information like trade secrets and personal data. Both meetings will be held virtually from the National Cancer Institute in Rockville, Maryland. The meetings aim to focus on different aspects of cancer research, including clinical and translational research, and biospecimen science approaches.

The National Institute on Drug Abuse announced several upcoming closed meetings. These meetings will be held virtually and are scheduled to evaluate grant applications. Participants will review confidential information, including potential trade secrets and personal details about individuals involved in the grant applications. Contact persons for each specific meeting are provided for further inquiries.

The National Institutes of Health (NIH) announced upcoming closed meetings for several of its review groups, scheduled from February 4-5, 2021. These meetings, held in accordance with federal law, are closed to the public to maintain confidentiality regarding grant applications and protect personal information. The review groups, including committees focused on neuroscience, biochemistry, cell biology, and oncology, will assess and evaluate grant applications. The meetings will be held virtually at the National Institutes of Health in Bethesda, Maryland.

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, is holding a closed meeting on March 18, 2021, from 10:00 a.m. to 5:00 p.m. The meeting aims to review and evaluate contract proposals for a project called the Transplantation Statistical and Clinical Coordinating Center (T-SCCC). Due to the sensitive nature of the material, including potential trade secrets and personal information, the meeting will not be open to the public. The contact person for this meeting is Dr. Konrad Krzewski.

The National Institutes of Health (NIH) has announced a series of closed meetings that will not be open to the public. These meetings are organized by different committees within the Center for Scientific Review and will evaluate grant applications. The discussions in these meetings will address confidential topics, including trade secrets, potential patents, and personal information. The meetings will take place virtually from February 10-13, 2025, with specific contact persons available for each committee to provide further information if needed.

The National Institute on Aging, part of the National Institutes of Health, announced a meeting that will be closed to the public. This meeting, scheduled for February 18, 2021, is intended to review and evaluate grant applications related to aging therapeutics. The meeting is closed to protect confidential information and personal privacy as required by specific U.S. legal provisions. The meeting will take place via a video meeting at the National Institute on Aging in Bethesda, Maryland, and will be managed by Dr. Birgit Neuhuber.

The National Institute of Environmental Health Sciences will hold several closed meetings in April 2025 to review and evaluate grant applications and contract proposals. These meetings will be conducted virtually and are closed to the public to protect confidential information and personal privacy. Details for each meeting, including dates, times, and contact information for the Scientific Review Officers, are provided. This action is pursuant to the Federal Advisory Committee Act.